Effect of glucosamine consumption on blood glucose and insulin levels in type 2 diabetic patients
Phase 2
- Conditions
- Type 2 diabetes mellitus.Non-insulin-dependent diabetes mellitus
- Registration Number
- IRCT2014031811785N2
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 58
Inclusion Criteria
Confirmed diagnosis of type 2 diabetes; fasting blood sugar <150 mg/dl; glycosylated hemoglobin <7%; management of diabetes with a stable dose of hypoglycemic drugs.
Exclusion criteria: Insulin therapy; having shellfish allergy; use of any medications which alter glucose control; having history of cardiovascular diseases and thyroid disorders
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fasting blood glucose. Timepoint: Weeks of 0, 4, 8 and 12. Method of measurement: Auto Analyzer, unit: mg/dl.;Fasting insulin. Timepoint: Weeks of 0, 8 and 12. Method of measurement: ELISA method, unit: µu/ml.;Glycosylated hemoglobin. Timepoint: Weeks of 0, 8 and 12. Method of measurement: Ion exchange chromatography, unit: percent.;HOMA index. Timepoint: Weeks of 0, 8 and 12. Method of measurement: According to formula.;QUICKI index. Timepoint: Weeks of 0, 8 and 12. Method of measurement: According to formula.
- Secondary Outcome Measures
Name Time Method Body mass index. Timepoint: Weeks of 0 and 12. Method of measurement: According to formula, unit: Kg/m2.